The amount of CD34+ vessels in the ULP area was not significantly changed in BPS, MS and CIS bladders compared to controls (LI, calculated by the percentage of CD34-positive tissue area in the ULP area) (Figs 5 and 6). The gene discussed is CD34; the disease is myeloid sarcoma.